| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/28/2011 | US20110098227 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 04/28/2011 | US20110098214 Lps or lipid a binding agent and novel peptide |
| 04/28/2011 | US20110098212 Cytokine |
| 04/28/2011 | US20110098207 Cellulase-Free Enzyme Compositions and Host Cells for Producing the Same |
| 04/28/2011 | US20110098200 Methods using dsdna to mediate rna interference (rnai) |
| 04/28/2011 | US20110098183 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
| 04/28/2011 | US20110098180 Herbicide-Resistant Plants, And Polynucleotides And Methods For Providing Same |
| 04/28/2011 | US20110097804 Targeted gene modification by parvoviral vectors |
| 04/28/2011 | US20110097803 CLDN5 Mini-Promoters |
| 04/28/2011 | US20110097798 Mammalian cell expression vectors and utilization |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097792 Interleukin-12p40 variants with improved stability |
| 04/28/2011 | US20110097791 Novel process, construct and conjugate for producing multiple nucleic acid copies |
| 04/28/2011 | US20110097783 Proteases from gram-positive organisms |
| 04/28/2011 | US20110097778 Chimeric alpha-amylase variants |
| 04/28/2011 | US20110097775 Production of butanol |
| 04/28/2011 | US20110097771 Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility |
| 04/28/2011 | US20110097761 Mutant muscle-specific enhancers |
| 04/28/2011 | US20110097741 Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays |
| 04/28/2011 | US20110097737 Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope |
| 04/28/2011 | US20110097733 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite |
| 04/28/2011 | US20110097731 Novel mitochondrial dye |
| 04/28/2011 | US20110097730 Recombinant Sars-Cov nsp12 and the Use of Thereof and the Method for Producing it |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097721 In vivo gene sensors |
| 04/28/2011 | US20110097715 Method for purifying or detecting a target protein |
| 04/28/2011 | US20110097709 Method for modifying a nucleic acid |
| 04/28/2011 | US20110097708 Assessment of human papilloma virus-related disease |
| 04/28/2011 | US20110097445 Protease variants |
| 04/28/2011 | US20110097357 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
| 04/28/2011 | US20110097354 System for the expression of peptides on the bacterial surface |
| 04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
| 04/28/2011 | US20110097346 Dendritic Cells |
| 04/28/2011 | US20110097342 Binding agents |
| 04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
| 04/28/2011 | US20110097339 Compositions monovalent for CD28 binding and methods of use |
| 04/28/2011 | US20110097338 Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy |
| 04/28/2011 | US20110097334 Novel Marker Genes for Regulatory T Cells from Human Blood |
| 04/28/2011 | US20110097333 Therapeutic and diagnostic agents |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097314 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 04/28/2011 | US20110097309 Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue |
| 04/28/2011 | US20110097271 Colon Cancer Associated Transcript 1 (CCAT1) As A Cancer Marker |
| 04/28/2011 | US20110097270 Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
| 04/28/2011 | US20110097262 NOVEL ANTI-cMET ANTIBODY |
| 04/28/2011 | DE112009000313T5 Pflanzen mit erhöhtem Ertrag Plants with increased yield |
| 04/28/2011 | CA2779234A1 Toxicity-associated genes, genetic variants, and use thereof |
| 04/28/2011 | CA2778695A1 Methods and compositions for enhancing polypeptide production |
| 04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 04/28/2011 | CA2778449A1 Amplification primers with non-standard bases for increased reaction specificity |
| 04/28/2011 | CA2778401A1 Integrin alpha 8-beta 1-specific monoclonal antibody |
| 04/28/2011 | CA2778391A1 A means for inducing apomixis in cultivated plants having sexual reproduction and use thereof for the production of completely or partially apomictic plants |
| 04/28/2011 | CA2778359A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
| 04/28/2011 | CA2778176A1 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | CA2777802A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/28/2011 | CA2777753A1 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
| 04/28/2011 | CA2775924A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | CA2774871A1 Screening method utilizing thalidomide-targeting factor |
| 04/28/2011 | CA2774032A1 Anti-gcc antibody molecules and related compositions and methods |
| 04/27/2011 | EP2315145A1 Methods, systems, and software for identifying functional biomolecules |
| 04/27/2011 | EP2315002A2 Filter module for an optical instrument used in particular for monitoring DNA polymerase chain reactions |
| 04/27/2011 | EP2314716A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/27/2011 | EP2314713A1 Oligonucleotide probe, and use thereof |
| 04/27/2011 | EP2314712A1 Expression vectors encoding epitopes of antigens and methods for their design |
| 04/27/2011 | EP2314711A1 Methods for expression and purification of immunotoxins |
| 04/27/2011 | EP2314708A1 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 04/27/2011 | EP2314707A1 Method for the expression of a recombinant protein in a mammalian cell |
| 04/27/2011 | EP2314706A2 Promotor, acetolactate synthase and process for transformation of thraustochytriales microorganisms |
| 04/27/2011 | EP2314705A2 Methods for altering the reactivity of plant cell walls |
| 04/27/2011 | EP2314704A1 Tomato fruit having increased firmness |
| 04/27/2011 | EP2314703A1 A plant promoter being tissue specific for endosperm and embryo of a plant seed |
| 04/27/2011 | EP2314702A1 Plant having resistance to low-temperature stress and method of production thereof |
| 04/27/2011 | EP2314701A2 Recombinant expression vector for animal cell |
| 04/27/2011 | EP2314700A1 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| 04/27/2011 | EP2314699A1 Medical preparations for the treatment of alpha-galactosidase A deficiency |
| 04/27/2011 | EP2314698A1 Xylanases, nucleic acids encoding them and methods for making and using them |
| 04/27/2011 | EP2314697A1 Streptococcus pneumoniae proteins and nucleic acids |
| 04/27/2011 | EP2314696A1 Therapeutic uses of human Interleukin-B50 antagonist. |
| 04/27/2011 | EP2314695A2 Ligand for receptor activator of NF-kappa B, ligand is member of TNF superfamily |
| 04/27/2011 | EP2314694A2 BAFF receptor (BCMA), an immunoregulatory agent |
| 04/27/2011 | EP2314693A2 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 04/27/2011 | EP2314692A2 Methods and compositions for enhancing the efficacy and specificity of RNAi |
| 04/27/2011 | EP2314691A2 Fuctional and hyperfunctional siRNA |
| 04/27/2011 | EP2314690A1 RNA-interference by single-stranded RNA molecules |
| 04/27/2011 | EP2314689A2 Antisense compounds targeted to connexins and methods of use thereof |
| 04/27/2011 | EP2314688A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 04/27/2011 | EP2314687A1 Inducible small interfering RNA (siRNA) expression constructs for targeted gene silencing |
| 04/27/2011 | EP2314686A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314685A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314684A1 Fluorescent protein and chromoprotein |
| 04/27/2011 | EP2314683A1 Fluorescent protein and chromoprotein |
| 04/27/2011 | EP2314682A2 Fluorescent protein |
| 04/27/2011 | EP2314681A1 Modified biotin-binding protein |
| 04/27/2011 | EP2314680A1 Method for amplification of target nucleic acid sequence, method for detection of mutation by using the method, and reagents for use in the methods |
| 04/27/2011 | EP2314679A1 Construction of expression system for rna polymerase derived from influenza virus, crystallization of the rna polymerase, and screening method for anti-influenza agent |
| 04/27/2011 | EP2314678A1 Micro-rna associated with rheumatoid arthritis |
| 04/27/2011 | EP2314677A1 Method for collection of nucleic acid from fecal sample, method for analysis of nucleic acid, and apparatus for treatment of fecal sample |
| 04/27/2011 | EP2314676A1 Compositions and methods for the treatment of immune related diseases |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314668A2 Gene inactivated mutants with altered protein production |